Increasing Market Exclusivity for New Drugs, the Cure for What Ails Us?: Patent Highlight

par Miller, Chris P.
Publié 2012

Quantitative Comparison of Erythropoietin Receptor Levels in the Epithelial versus Endothelial Fractions of Primary Breast Tumors

par Miller, Chris P., Urban, Nicole, Blau, C. Anthony
Publié 2011

Limitations of a Murine Transgenic Breast Cancer Model for Studies of Erythropoietin-Induced Tumor Progression

par Miller, Chris P, Valliant-Saunders, Karine, Blau, Carl Anthony
Publié 2010

Current status of antigen-specific T-cell immunotherapy for advanced renal-cell carcinoma

par Xu, Yuexin, Miller, Chris P., Warren, Edus H., Tykodi, Scott S.
Publié dans Hum Vaccin Immunother (2021)

A 3D Human Renal Cell Carcinoma-on-a-Chip for the Study of Tumor Angiogenesis()

par Miller, Chris P., Tsuchida, Connor, Zheng, Ying, Himmelfarb, Jonathan, Akilesh, Shreeram
Publié dans Neoplasia (2018)

MicroRNA expression dynamics during murine and human erythroid differentiation

par Zhan, Mei, Miller, Chris P, Papayannopoulou, Thalia, Stamatoyannopoulos, George, Song, Chao-Zhong
Publié 2007

Engineering Microphysiological Immune System Responses on Chips

par Miller, Chris P., Shin, Woojung, Ahn, Eun Hyun, Kim, Hyun Jung, Kim, Deok-Ho
Publié dans Trends Biotechnol (2020)

Sparse expression bases in cancer reveal tumor drivers

par Logsdon, Benjamin A., Gentles, Andrew J., Miller, Chris P., Blau, C. Anthony, Becker, Pamela S., Lee, Su-In
Publié dans Nucleic Acids Res (2015)

Selective Androgen Receptor Modulator RAD140 Is Neuroprotective in Cultured Neurons and Kainate-Lesioned Male Rats

par Jayaraman, Anusha, Christensen, Amy, Moser, V. Alexandra, Vest, Rebekah S., Miller, Chris P., Hattersley, Gary, Pike, Christian J.
Publié 2014

A hyperactive Mpl-based cell growth switch drives macrophage-associated erythropoiesis through an erythroid-megakaryocytic precursor

par Belay, Eyayu, Miller, Chris P., Kortum, Amanda N., Torok-Storb, Beverly, Blau, C. Anthony, Emery, David W.
Publié dans Blood (2015)

Evaluating Erythropoietin-Associated Tumor Progression Using Archival Tissues from a Phase III Clinical Trial

par Miller, Chris P., Lowe, Kimberly A., Valliant-Saunders, Karine, Kaiser, Joringel F., Mattern, Dominik, Urban, Nicole, Henke, Michael, Blau, C. Anthony
Publié 2009

The proteomic landscape of triple-negative breast cancer

par Lawrence, Robert T., Perez, Elizabeth M., Hernández, Daniel, Miller, Chris P., Haas, Kelsey M., Irie, Hanna Y., Lee, Su-In, Blau, C. Anthony, Villén, Judit
Publié dans Cell Rep (2015)

JAK2 Expression is Associated with Tumor-Infiltrating Lymphocytes and Improved Breast Cancer Outcomes: Implications for Evaluating JAK2 Inhibitors

par Miller, Chris P., Thorpe, Jason D., Kortum, Amanda N., Coy, Catherine M., Cheng, Wei-Yi, Yang, Tai-Hsien Ou, Anastassiou, Dimitris, Beatty, J. David, Urban, Nicole D., Blau, C. Anthony
Publié 2014

A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia

par Lee, Su-In, Celik, Safiye, Logsdon, Benjamin A., Lundberg, Scott M., Martins, Timothy J., Oehler, Vivian G., Estey, Elihu H., Miller, Chris P., Chien, Sylvia, Dai, Jin, Saxena, Akanksha, Blau, C. Anthony, Becker, Pamela S.
Publié dans Nat Commun (2018)

Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator (SARM) RAD140

par Miller, Chris P., Shomali, Maysoun, Lyttle, C. Richard, O’Dea, Louis St. L., Herendeen, Hillary, Gallacher, Kyla, Paquin, Dottie, Compton, Dennis R., Sahoo, Bishwabhusan, Kerrigan, Sean A., Burge, Matthew S., Nickels, Michael, Green, Jennifer L., Katzenellenbogen, John A., Tchesnokov, Alexei, Hattersley, Gary
Publié 2010

Integrated epigenomic profiling reveals endogenous retrovirus reactivation in renal cell carcinoma

par Siebenthall, Kyle T., Miller, Chris P., Vierstra, Jeff D., Mathieu, Julie, Tretiakova, Maria, Reynolds, Alex, Sandstrom, Richard, Rynes, Eric, Haugen, Eric, Johnson, Audra, Nelson, Jemma, Bates, Daniel, Diegel, Morgan, Dunn, Douglass, Frerker, Mark, Buckley, Michael, Kaul, Rajinder, Zheng, Ying, Himmelfarb, Jonathan, Ruohola-Baker, Hannele, Akilesh, Shreeram
Publié dans EBioMedicine (2019)